Company lowers full-year revenue forecast to $2.85B-$2.89B from prior $3.45B-$3.52B, missing consensus of $3.49B.
AdaptHealth Corp. shares plunged approximately 42% in early trading Tuesday after reporting second-quarter results that fell short of expectations and reducing its 2026 revenue guidance. The company now expects full-year net revenue of $2.85 billion to $2.89 billion, down from a previous forecast of $3.45 billion to $3.52 billion.
Analysts had anticipated revenue of $3.49 billion for the year. The revised outlook reflects weaker-than-expected performance in the quarter, though specific Q2 figures were not detailed in the initial report.
The sharp decline in share price underscores investor concerns over the company’s growth trajectory and financial health amid the lowered projections.